CTRI Number |
CTRI/2016/12/007529 [Registered on: 02/12/2016] Trial Registered Retrospectively |
Last Modified On: |
11/12/2018 |
Post Graduate Thesis |
No |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
Randomozed,Blinded, placebo controlled, clinical study to evaluate the efficacy of Dabur Babool Neem Toothpaste DRDC/PC/8003 in oral hygeine and dental care |
Scientific Title of Study
|
A Double blind, randomized, placebo controlled, clinical study to evaluate the efficacy of a Dabur Babool Neem Toothpaste DRDC/PC/8003 in oral hygeine and dental care |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Rahul Bhowate |
Designation |
Professor |
Affiliation |
Department of Oral medine & Radiology, Sharad Pawar Dental College & Hospital, Wardha |
Address |
Department of Oral medine & Radiology, Sharad Pawar Dental College & Hospital, Wardha
Wardha MAHARASHTRA 442001 India |
Phone |
07152245968 |
Fax |
|
Email |
dr_bhowate@yahoo.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Arun Gupta |
Designation |
Head-Medical Affairs & Clinical Resaerch |
Affiliation |
Dabur India ltd. |
Address |
Dabur Research & Development Center, Dabur India Ltd., Sahibabd, Ghaziabad (U.P)
Ghaziabad UTTAR PRADESH 201010 India |
Phone |
012033878614 |
Fax |
|
Email |
arun.gupta@dabur.com |
|
Details of Contact Person Public Query
|
Name |
Sunil Kumar |
Designation |
Research Scientist |
Affiliation |
Dabur India ltd. |
Address |
Dabur Research & Development Center, Dabur India Ltd., Sahibabd, Ghaziabad (U.P)
Ghaziabad UTTAR PRADESH 201010 India |
Phone |
0120338562 |
Fax |
|
Email |
sunil.kumar@dabur.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
Dabur India Ltd |
Address |
Dabur Research & Development Center, dabiu India Ltd., Sahibabd, Ghaziabad (U.P |
Type of Sponsor |
Pharmaceutical industry-Global |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Rahul Bhowate |
Department of Oral Medicine & Radiology, Sharad Pawar Dental College & Hospital |
DEPARTMENT OF ORAL MEDICINE & RADIOLOGY
SHARAD PAWAR DENTAL COLLEGE
SAWANGI (MEGHE)
WARDHA (MAHARASHTRA)
PIN - 442004
Wardha MAHARASHTRA |
07152245968
dr_bhowate@yahoo.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Instittutional Ethics Committee, Datta Meghe Institute of Medical Sciences University |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
Modification(s)
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: K051||Chronic gingivitis, (2) ICD-10 Condition: K053||Chronic periodontitis, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Intervention |
Dabur Babool Neem Toothpaste (DRDC/PC/8003) |
Subject were advised to brush with Babool Neem Toothpaste two times a day for 12 week |
Comparator Agent |
Placebo |
Subjects were advised to brush two times a day for 6 weeks |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
45.00 Year(s) |
Gender |
Both |
Details |
Periodontitis & Gingival Group:
1. Subjects of both sexes in the age groups of 18-45 yrs
2. Subjects willing to sign informed consent form
3. Subjects who have at least 20 natural uncrowned teeth excluding third molars.
4. Subjects with periodontitis and gingivitis
5. Subjects with ability to comply with all study requirements.
6. Subjects having gingivitis with gingival index > 1 at more than 60 % of sites examined.
7. Subjects with tooth stains.
8. Subjects having dental plaque with plaque index of 2 or more.
Healthy Group:
1. Healthy subjects of both sexes in the age group of 18 to 45 years.
2. Subjects willing to sign informed consent form.
3. Subjects who have at least 20 natural uncrowned teeth excluding third molars.
4. Subjects with ability to comply with all study requirements.
|
|
ExclusionCriteria |
Details |
Periodontitis & Gingival Group:
1. Subjects having pain and multiplicity of periodontal/gingival problems or advanced generalized chronic inflammatory periodontal disease or any gross oral pathology.
2. Subjects having history of known sensitivity or oral mucosal tissue reaction to toothpaste.
3. Subjects having any serious systemic disease.
4. Subjects with any external dental treatment like scaling, polishing, flossing etc.
5. Subjects with Upper respiratory tract infection, Urinary tract infection, Gastrointestinal Tract infection, Skin infection.
6. Subjects with history of intake of antibiotics and anti-inflammatory drugs for the past 3-4 weeks
7. Subjects with history of fluoride treatment for the past two weeks.
8. Pregnant or lactating mothers.
9. Subjects with involvement in any concurrent study the nature of which may affect the parameters being investigated in the study.
10. Subjects not willing to sign informed consent.
11. Subjects not willing to come for follow-up when required
12. Subjects with presence of relatively severe tetracycline stained teeth.
Healthy Group:
As per the exclusion criteria for gingivitis & periodontitis group.
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Pre-numbered or coded identical Containers |
Blinding/Masking
|
Participant and Investigator Blinded |
Primary Outcome
|
Outcome |
TimePoints |
For GIngivitis & Periodontitis Group:
change in scores of gingivitis &/or signs & symptoms, change in microbiologiacl assesment (swab culture), elimination/reduction in malodor if applicable, change in scores of lobene stain &/or signs & symptoms, change in plaque scores &/or signs & symptoms, change in clinivcal attachement loss
For Healthy Group:
Reduction in microbial counts (swab culture) |
12 weeks for gingivits & periodontitis group & 6 weeks for healthy group |
|
Secondary Outcome
|
Outcome |
TimePoints |
For GIngivitis & Periodontitis Group:
Global patient & Investigator evaluation, ADR/AE profile
For Healthy Group:
Lobene index, organoleptic index, plaque assesment/plaque index, gingival index, clinical attachment loss, ADR/AE profile |
12 weeks for gingivits & periodontitis group & 6 weeks for healthy group
|
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
24/09/2010 |
Date of Study Completion (India) |
Date Missing |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Date Missing |
Estimated Duration of Trial
|
Years="0" Months="8" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Completed |
Publication Details
|
Result s of the study of this clinical Trial may be used for publishing scientific papers. |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
Brief Summary
|
This is a single centerd, Double Blind; Placebo Controlled; randomized, clinical study to evaluate the efficacy of a Dabur Babool Neem Toothpaste in oral Hygiene and Dental Care. 50 subjects were enrolled in the study on the basis of two groups one group is diseased group having Gingivitis and Periodontitis and 20 Healthy Volunteers were enrolled in other group. For Gingivitis and Periodontitis group Duration of the study was 12 weeks of use of product and one week follow up where as in Healthy group duration of study was 6 weeks of use of product.Subjects were assessed on various parameters like: Change in pH of saliva,change in pH of gingival crevicular fluid,change in gingival crevicular flow,reduction in microbial counts (swab culture)change in malodor,change in stain score,change in gingival index,change in plaque scores,change in clinical attachment loss scores,global patient evaluation,global physical evaluation,Adverse Reactions/Adverse Events. |